PubMed Indexed | Fully Open Access | Cell Biology Journals

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Cell Biology in Medicine

Open Access Journals

Looking to publish your next article?

 

Each journal in this portfolio is PubMed indexed, peer-reviewed and fully open access; aiming to serve the academic research community.

 

The below journals have various specialties in:

  • antibody research and development
  • enzyme inhibitors and inhibitory processes
  • medicinal and anti-cancer agents
  • metalloproteinases
  • and stem cell research

 

Explore the links below to discover our range of open access journals and find the perfect home for your research.

Publishing Open Access

Taylor & Francis offers publishing options that support the needs of authors and researchers worldwide. To learn more about open access publishing, click the link below.
LEARN MORE ABOUT PUBLISHING OPTIONS

mAbs

An open access journal | 2019 Impact Factor 4.634

A multi-disciplinary journal dedicated to the art and science of antibody research and development. mAbs has a strong scientific and medical focus, which strives to serve a broader readership of scientists, clinical researchers, and physicians, as well as the wider mAb community, including our readers involved in technology transfer, legal issues, investment, strategic planning and the regulation of therapeutics.

mAbs publishes relevant and timely original research, as well as authoritative overviews, commentary and perspectives providing context for the work presented in mAbs and for key results published elsewhere.

GO TO MABS

Journal of Enzyme Inhibition and Medicinal Chemistry

An open access journal | 2019 Impact Factor 4.673

Publishing new knowledge and findings on enzyme inhibitors and inhibitory processes and agonist/antagonist receptor interactions in the development of medicinal and anti-cancer agents and an understanding of their action.

Among various fields of study, special attention is given to structure and molecular aspects, enzyme kinetics and inactivation mechanisms, structure-activity relationships (QSAR, graphic techniques), drug development studies, drug release and control mechanisms in metabolic processes.

GO TO JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Metalloproteinases In Medicine

A Dove Medical Press journal, part of Taylor & Francis Group, the Academic Publishing Division of Informa Plc

Metalloproteinases In Medicine aims to provide a platform for the discussion and dissemination of knowledge about the role that metalloproteinases – such as matrix metalloproteinases (MMP), ADAMs, ADAMTSs, and astacins, as well as their inhibitors - play in diseases.

This unique journal publishes original research articles, reviews, methodological progression, clinical studies and expert opinions to highlight current and topical advances in the field of metalloproteinases with special regard to pathogenesis of various diseases and the potential therapeutic possibilities that lie within. 

GO TO METALLOPROTEINASES IN MEDICINE

Stem Cells and Cloning: Advances and Applications

A Dove Medical Press journal, part of Taylor & Francis Group, the Academic Publishing Division of Informa Plc

Stem Cells and Cloning: Advances and Applications publishes original research, reviews, hypothesis formation, commentaries, technology reviews and short reports in established and emerging concepts in stem cell research.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

GO TO STEM CELLS AND CLONING

Dove Medical Press Author Program

Learn how you can receive fast-track processing of papers, the rapid delivery of a PDF of your paper and a 10% discount on the article publishing charge.
LEARN MORE

Cogent Medicine

Cogent Medicine, part of Taylor & Francis Group, publishes experimental, translational and clinical approaches across all areas of biomedical sciences, clinical research and practice.
GO TO COGENT MEDICINE

F1000Research

An open research publishing platform offering rapid publication of articles and other research outputs. All articles benefit from transparent peer-review and the inclusion of all source data.
GO TO F1000RESEARCH